Jorge J. Castillo, Joshua N. Gustine, Kirsten Meid, Catherine A. Flynn, Maria G. Demos, Maria L. Guerrera, Cristina Jimenez, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J. Patterson, Lian Xu, Guang Yang, Zachary R. Hunter, Steven P. Treon
CXCR4 mutational status does not impact outcomes in patients w WM treated with proteosome inhibitors
Am Journal of Hematology: Received: 3 January 2020 Accepted: 8 January 2020 DOI: 10.1002/ajh.25730